The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation between infarct volume and functional outcome in treated patients at 90 days post-procedure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Functional Outcome as Defined by a mRS of 0-2 at 90 Days Post-procedure
Timeframe: At 90 days post-procedure
Angiographic Assessment of Vessel Patency as Measured by TIMI Score
Timeframe: At immediate post-procedure
Angiographic Assessment of Vessel Patency as Measured by Modified TICI Score
Timeframe: At immediate post-procedure
Procedural Serious Adverse Events During the Procedure
Timeframe: During the procedure, approximately 24 hours